Skip to main content

Table 4 Logistic regression of probability of hospitalization of cystic fibrosis patients, N = 804.

From: Adherence with tobramycin inhaled solution and health care utilization

 

AOR*

95% CI

Overall adherence with TIS

  

   Low (reference)

1.0

 

   Medium

0.94

0.62-1.41

   High

0.40

0.19-0.84

Age (in years)

  

   <6 (reference)

1.0

 

   6-10

1.76

0.89-3.47

   11-17

1.52

0.86-2.69

   18-25

1.48

0.80-2.73

   ≥26

0.73

0.38-1.39

Gender

  

   Male (reference)

1.0

 

   Female

1.04

0.74-1.44

Comorbidity score

  

   ≤Average (reference)

1.0

 

   >Average

7.53**

5.20-10.90

Selected comorbidity

  

   Pseudomonas aeruginosa

3.0**

2.13-4.32

   Failure to thrive/growth failure

2.8**

1.09-7.14

  1. *Adjusted for variables in the table and health plan type and geographic residence; **p < 0.05
  2. AOR = adjusted odds ratio; CI = confidence interval; TIS = tobramycin